Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2017 · 84 citations · 25 references
MedicineOncologyPathologyNeoplasiaThoracic OncologyTumor PathologyLung CancerMalignant NeoplasmsMalignant TumorsPulmonary PathologyThoracic Tumor PathologyTumor ClassificationLung Cancer CytologyLung Cancer PathologyLung Tumor ClassificationPulmonary Carcinoid TumorsPulmonary NeoplasiaPulmonary NeoplasmsPulmonary Neuroendocrine Tumors
Typical (TCs) and atypical carcinoids (ACs) are defined based on morphological criteria, and no grading system is currently accepted to further stratify these entities. The 2015 WHO classification restricts the Ki-67 role to biopsy or cytology samples, rather than for prognostic prediction. We aimed to investigate whether values and patterns of Ki-67 alone would allow for a clinically meaningful stratification of lung carcinoids, regardless of histological typing. Ki-67 proliferation index and pattern (homogeneous versus heterogeneous expression) were assessed in a cohort of 171 TCs and 68 ACs. Cases were subdivided into three Ki-67 ranges (<4/4-9/≥10%). Correlations with clinicopathological data, univariate and multivariate survival analyses were performed. The majority of cases (61.5%) belonged to the <4% Ki-67 range; 25.1 and 13.4% had a proliferation index of 4-9% and ≥10%, respectively. The <4% Ki-67 subgroup was significantly enriched for TCs (83%, p < 0.0001); ACs were more frequent in the subgroup showing Ki-67 ≥ 10% (75%, p < 0.0001). A heterogeneous Ki-67 pattern was preferentially seen in carcinoids with a Ki-67 ≥10% (38%, p < 0.02). Mean Ki-67 values ≥4 and ≥10% identified categories of poor prognosis both in terms of disease-free and overall survival (p = 0.003 and <0.0001). At multivariate analysis, the two thresholds did not retain statistical significance; however, a Ki-67 ≥ 10% identified a subgroup of dismal prognosis even within ACs (p = 0.03) at univariate analysis. Here, we describe a subgroup of lung carcinoids showing brisk proliferation activity within the necrosis and/or mitotic count-based categories. These patients were associated with specific clinicopathological characteristics, to some extent regardless of histological subtyping.
25
Natasha Rekhtman, M. Catherine Pietanza, Matthew D. Hellmann et al. · Clinical Cancer Research · 2016 · 472 citations · Full text
Neuroendocrine Neoplasms of the Lung: A Prognostic Spectrum
Hisao Asamura, Toru Kameya, Yoshihiro Matsuno et al. · Journal of Clinical Oncology · 2005 · 466 citations · Full text
Laura H. Tang, Olca Baştürk, Jillian Sue et al. · The American Journal of Surgical Pathology · 2016 · 369 citations
Laura H. Tang, Brian R. Untch, Diane Reidy‐Lagunes et al. · Clinical Cancer Research · 2015 · 351 citations · Full text
Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival
Luc G.T. Morris, Nadeem Riaz, Alexis Desrichard et al. · Oncotarget · 2016 · 307 citations · Full text